External Email - Use Caution        

Hi Carly,


plus, if I may answer in addition, make sure that the ICV differences are 
checked with sex as covariate,

so that statement of yours is only valid, if analyzed also per sex separately, 
or with sex as covariate.


Next, you should also (once) test for ICV-by-Dgx effects, as you cannot know in 
advance, if the relationship

between ICV and local measures is the same.


Best,

Philipp Sämann


________________________________
Von: freesurfer-boun...@nmr.mgh.harvard.edu 
<freesurfer-boun...@nmr.mgh.harvard.edu> im Auftrag von Iglesias Gonzalez, Juan 
E. <jiglesiasgonza...@mgh.harvard.edu>
Gesendet: Montag, 8. Juli 2024 19:39
An: Freesurfer support list
Betreff: Re: [Freesurfer] Is ICV needed as a covariate if matched between groups


It’s always a good idea to divide the volumes by ICV (or add ICV as a 
regressor). This is very unlikely, but what if your controls happened to have 
smaller heads than your patients? For peace of mind, I’d correct by ICV.

Cheers,

/Eugenio



--

Juan Eugenio Iglesias

http://www.jeiglesias.com



From: freesurfer-boun...@nmr.mgh.harvard.edu 
<freesurfer-boun...@nmr.mgh.harvard.edu> on behalf of Carly McIntyre-Wood 
<mcint...@mcmaster.ca>
Date: Monday, July 8, 2024 at 12:06 PM
To: freesurfer@nmr.mgh.harvard.edu <freesurfer@nmr.mgh.harvard.edu>
Subject: [Freesurfer] Is ICV needed as a covariate if matched between groups

        External Email - Use Caution

Hi there,



I am investigating differences in hipp/amyg volume between a patient and HC 
sample and am wondering if there is any reason I would still need to include 
ICV as a covariate if the groups do not differ on ICV (p=.793).



Thanks so much,

Carly
_______________________________________________
Freesurfer mailing list
Freesurfer@nmr.mgh.harvard.edu
https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
The information in this e-mail is intended only for the person to whom it is 
addressed.  If you believe this e-mail was sent to you in error and the e-mail 
contains patient information, please contact the Mass General Brigham 
Compliance HelpLine at https://www.massgeneralbrigham.org/complianceline 
<https://www.massgeneralbrigham.org/complianceline> .
Please note that this e-mail is not secure (encrypted).  If you do not wish to 
continue communication over unencrypted e-mail, please notify the sender of 
this message immediately.  Continuing to send or respond to e-mail after 
receiving this message means you understand and accept this risk and wish to 
continue to communicate over unencrypted e-mail. 

Reply via email to